Dermapharm Holding SE buy DirectorDealer
Start price
07.01.26
/
50%
€38.50
Target price
07.01.27
-
Performance (%)
6.18%
Price
18.08.26
€40.00
Summary
This prediction is currently active. The BUY prediction by DirectorDealer shows slight gains of 6.18%. A total of €0.88 was paid as dividends for this prediction. This prediction currently runs until 07.01.27. The prediction end date can be changed by DirectorDealer at any time. DirectorDealer has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Dermapharm Holding SE | 0.629% | 0.629% |
| iShares Core DAX® | -0,05 % | 5,96 % |
| iShares Nasdaq 100 | 0,92 % | 3,69 % |
| iShares Nikkei 225® | 3,01 % | 6,64 % |
| iShares S&P 500 | -0,36 % | 2,75 % |
Comments by DirectorDealer for this prediction
In the thread Dermapharm Holding SE diskutieren
Director's Dealing / Insider Kauf von Dreibholz, Christof (Vorstand)
- Handelstag: 05.01.2026
- Volumen: 95825 €
- Meldende_r: Dreibholz, Christof